Funds · SONN

Who owns SONN?

No institutional manager reported a Sonnet BioTherapeutics Holdings Inc. position in the latest Form 13F data we have. 13F covers US-listed shares held by managers with at least $100 million in such securities.

SONN news and filings · Top funds